Acute liver graft rejection after ipilimumab therapy

Ann Oncol. 2017 Oct 1;28(10):2619-2620. doi: 10.1093/annonc/mdx281.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antineoplastic Agents, Immunological / adverse effects*
  • Antineoplastic Agents, Immunological / therapeutic use
  • Eye Neoplasms / drug therapy*
  • Eye Neoplasms / pathology
  • Eye Neoplasms / surgery
  • Female
  • Graft Rejection / chemically induced*
  • Graft Rejection / pathology
  • Humans
  • Ipilimumab / adverse effects*
  • Ipilimumab / therapeutic use
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / secondary
  • Liver Neoplasms / surgery
  • Liver Transplantation
  • Melanoma / drug therapy*
  • Melanoma / pathology
  • Melanoma / surgery

Substances

  • Antineoplastic Agents, Immunological
  • Ipilimumab